Clinical Implication of FDG-PET in Advanced Gastric Cancer With Signet Ring Cell Histology

被引:27
|
作者
Pak, Kyung Ho [1 ]
Yun, Mijin [2 ]
Cheong, Jae-Ho [1 ]
Hyung, Woo Jin [1 ]
Choi, Seung Ho [1 ]
Noh, Sung Hoon [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul 120752, South Korea
关键词
standard uptake values; signet ring cell carcinoma; FDG-PET; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LUNG-CANCER; PROGNOSTIC VALUE; POOR-PROGNOSIS; CARCINOMA; ADENOCARCINOMA; CHEMOTHERAPY; PREDICTION; SURVIVAL;
D O I
10.1002/jso.21997
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: The purpose of this study was to investigate the role of the standardized uptake values (SUV), a semi-quantitative assessment of tumor FDG uptake, as a prognosticator for advanced signet ring cell carcinoma (SRC). Methods: We reviewed the files of 41 patients who underwent curative gastrectomy for advanced SRC and who had an FDG-PET at initial presentation between September 2003 and December 2007. Results: The median follow-up period was 30.9 months (range: 4.0-70.3). We found a correlation between the SUVmax and TNM stage. When the patients were divided into two groups (low vs. high SUVmax) based on a median SUVmax of 3.80, the high-SUVmax group showed more aggressive tumor behavior than did the low SUVmax group. In addition, the high SUVmax group showed more postoperative recurrence (P = 0.028), shorter relapse-free survival (P = 0.004), and lower 30-month cancer-specific survival rates (40.0% vs. 69.3%, P = 0.008). However, in multivariate analysis, SUVmax failed to be an independent predictor of overall survival. Conclusions: Although SUVmax of initial PET scan was not an independent predictor of patient outcomes after curative surgery, higher SUVmax is associated with more advanced stage and indicates more aggressive tumor biology in advanced SRC. J. Surg. Oncol. 2011;104:566-570. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:566 / 570
页数:5
相关论文
共 50 条
  • [41] The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma
    Lauren M. Postlewait
    Malcolm H. Squires
    David A. Kooby
    George A. Poultsides
    Sharon M. Weber
    Mark Bloomston
    Ryan C. Fields
    Timothy M. Pawlik
    Konstantinos I. Votanopoulos
    Carl R. Schmidt
    Aslam Ejaz
    Alexandra W. Acher
    David J. Worhunsky
    Neil Saunders
    Douglas Swords
    Linda X. Jin
    Clifford S. Cho
    Emily R. Winslow
    Kenneth Cardona
    Charles A. Staley
    Shishir K. Maithel
    [J]. Annals of Surgical Oncology, 2015, 22 : 832 - 839
  • [42] Tailored treatment for signet ring cell gastric cancer
    Mengardo, V.
    Treppiedi, E.
    Bencivenga, M.
    Dal Cero, Mariagiulia
    Giacopuzzi, S.
    [J]. UPDATES IN SURGERY, 2018, 70 (02) : 167 - 171
  • [43] The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma
    Postlewait, Lauren M.
    Squires, Malcolm H., III
    Kooby, David A.
    Poultsides, George A.
    Weber, Sharon M.
    Bloomston, Mark
    Fields, Ryan C.
    Pawlik, Timothy M.
    Votanopoulos, Konstantinos I.
    Schmidt, Carl R.
    Ejaz, Aslam
    Acher, Alexandra W.
    Worhunsky, David J.
    Saunders, Neil
    Swords, Douglas
    Jin, Linda X.
    Cho, Clifford S.
    Winslow, Emily R.
    Cardona, Kenneth
    Staley, Charles A.
    Maithel, Shishir K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S832 - S839
  • [44] Evaluation of the usefulness of FDG-PET/CT in diagnosis and qualification for surgical treatment of advanced gastric cancer
    Staniuk, Tomasz
    Jankowski, Michal
    Zegarski, Wojciech
    Malkowski, Bogdan
    Kula, Zbigniew
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (05): : 302 - 309
  • [45] Tailored treatment for signet ring cell gastric cancer
    V. Mengardo
    E. Treppiedi
    M. Bencivenga
    Mariagiulia Dal Cero
    S. Giacopuzzi
    [J]. Updates in Surgery, 2018, 70 : 167 - 171
  • [46] Signet Ring Cell Gastric Cancer: Harbinger of Doom?
    Taghavi, S.
    Jayarajan, S. N.
    Davey, A.
    Willis, A. I.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S159 - S160
  • [47] Accuracy of FDG-PET in gastric cancer - Preliminary experience.
    Yeung, HWD
    Macapinlac, H
    Akhurst, T
    Karpeh, M
    Finn, RD
    Larson, SM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05): : 135P - 135P
  • [48] FDG-PET in a case of multiple bone metastases of gastric cancer
    Takako Nakai
    Chio Okuyama
    Takao Kubota
    Yo Ushuima
    Tsunehiko Nishimura
    [J]. Annals of Nuclear Medicine, 2005, 19 : 51 - 54
  • [49] The role of FDG-PET/CT in detection of gastric cancer recurrence
    Tamam, M. O.
    Yavuz, H. S.
    Mulazimoglu, M.
    Eker, O.
    Ozpacaci, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S432 - S432
  • [50] FDG-PET in a case of multiple bone metastases of gastric cancer
    Nakai, T
    Okuyama, C
    Kubota, T
    Ushijima, Y
    Nishimura, T
    [J]. ANNALS OF NUCLEAR MEDICINE, 2005, 19 (01) : 51 - 54